82 Unveiling the effect of elexacaftor/tezacaftor/ivacaftor therapy on Pseudomonas aeruginosa persistence and adaptation through RNA expression profiling
M. Letizia, L. Whiteley, F. Diggle, E. McKone, P. Singh, M. Whiteley
{"title":"82 Unveiling the effect of elexacaftor/tezacaftor/ivacaftor therapy on Pseudomonas aeruginosa persistence and adaptation through RNA expression profiling","authors":"M. Letizia, L. Whiteley, F. Diggle, E. McKone, P. Singh, M. Whiteley","doi":"10.1016/S1569-1993(24)00924-X","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15452,"journal":{"name":"Journal of Cystic Fibrosis","volume":"23 ","pages":"Page S44"},"PeriodicalIF":5.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cystic Fibrosis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S156919932400924X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
期刊介绍：
The Journal of Cystic Fibrosis is the official journal of the European Cystic Fibrosis Society. The journal is devoted to promoting the research and treatment of cystic fibrosis. To this end the journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis. The journal also publishes news and articles concerning the activities and policies of the ECFS as well as those of other societies related the ECFS.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
